Drug Discovery World

SEPTEMBER 11, 2023

Artificial intelligence (AI) technology has the potential to revolutionise drug discovery and pharma companies need to make plans for a future in which AI is frequently utilised in research, says ResearchAndMarkets.com. The report points towards inorganic strategies amongst market players that are boosting AI in drug discovery.

Pharma Companies 147

Pharma Companies Pharmaceuticals Marketing Disease 147

Drug Discovery World

AUGUST 8, 2023

According to a report by Deloitte, globally India is the third largest in the world by volume and 11th by value, comprising over 3,000 pharma companies and 10,500 manufacturing facilities 2. To many, the country is referred to as the ‘pharmacy of the world’. So, what is driving this success, and will it continue?

Research 130

Research Pharmacy Pharmaceuticals Government 130

Drug Discovery World

SEPTEMBER 28, 2022

Its application in pharma, most commonly in drug discovery, has been steadily growing with global partnerships between tech vendors and pharma companies becoming more commonplace. According to Hampleton Patners’ latest Healthtech M&A market report2, digital health companies raised a total of $57.2

Pharma Companies 130

Pharma Companies Hospitals Clinical Trials Drugs 130

Alta Sciences

APRIL 5, 2024

CROs have historically functioned as auxiliaries to pharma companies, conducting the work sponsors can’t do in-house. A McKinsey & Company report from 2022 also found that biotech companies often rely heavily on CROs to compensate for their relative lack of “infrastructure”. billion by 2028—a CAGR growth rate of 10.7%

Drug Development 52

Drug Development Pharma Companies Marketing International 52